Life (Jan 2024)

One-Day Interruption of NOAC Is Associated with Low Risk of Periprocedural Adverse Events during Pulmonary Vein Isolation If Combined with Left Atrial Thrombus Exclusion with Computed Tomography

  • Katalin Piros,
  • Adorján Vida,
  • Nándor Szegedi,
  • Péter Perge,
  • Zoltán Salló,
  • Arnold Béla Ferencz,
  • Vivien Klaudia Nagy,
  • Szilvia Herczeg,
  • Pál Ábrahám,
  • Csaba Csobay-Novák,
  • Zsófia Drobni,
  • Tamás Tahin,
  • Györgyi Apponyi,
  • Béla Merkely,
  • László Gellér,
  • István Osztheimer

DOI
https://doi.org/10.3390/life14010133
Journal volume & issue
Vol. 14, no. 1
p. 133

Abstract

Read online

Background: Safety, efficacy, and patient comfort are the expectations during pulmonary vein isolation (PVI). We aimed to validate the combined advantages of pre- and periprocedural anticoagulation with non-vitamin K anticoagulants (NOACs) and rigorous left atrial appendage thrombus (LAAT) exclusion with computed tomography (CT). Methods: This study included a population of consecutive patients, between March 2018 and June 2020, who underwent cardiac CT within 24 h before PVI to guide the ablation and rule out LAAT. NOAC was omitted 24 h before the ablation. Results: A total of 187 patients (63% male) underwent CT before PVI. None of the patients experienced stroke during or after the procedure. The complication rate was low, with no thromboembolic events and 2.1% of patients experiencing a major bleeding event. Conclusions: Omitting NOAC 24 h before the ablation might be safe if combined with left atrial thrombus exclusion with computed tomography.

Keywords